2007 Press Releases
Sigma-Aldrich Grants Pfizer Non-Exclusive Worldwide License to Use ddRNAi in Research Programs..
Oxford BioMedica And Sigma-Aldrich Issue Joint License for Lentivector® Technology To Glaxosmithkline.
2006 Press Releases
Sigma-Aldrich and Oxford BioMedica Pursue Protection of RNAi-Related Intellectual Property; File Suit Against Open Biosystems.
Sigma-Aldrich and Rosetta Inpharmatics Establish Partnership for siRNA Design.
Scientists Publish Results on Sigma-Aldrich's shRNA Library in Cell.
Sigma-Aldrich Strengthens Position in RNAi and Cell-Based Assays Through Licensing and Equity Position in Genospectra.
Sigma-Aldrich Launches First Lentiviral shRNA Gene Family Set.
Sigma-Aldrich expands shRNA Libraries of The RNAi Consortium.
2005 Press Releases
Sigma-Aldrich strengthens its position in RNAi through licensing and Equity Positions in both Benitec and Oxford BioMedica.
Benitec grants Sigma-Aldrich license to RNAi Patent portfolio.
Send this page to a colleague.
Contact Us
For questions about the library, pricing and quotes or other concerns, please e-mail us at: RNAi@sial.com.
MISSION is a registered trademark of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co. Label License.
back to top
RNAi Homepage
|
